Compare VERA & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | ALHC |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 2021 | 2021 |
| Metric | VERA | ALHC |
|---|---|---|
| Price | $34.10 | $13.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $81.30 | $23.13 |
| AVG Volume (30 Days) | 2.0M | ★ 5.0M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $3,948,719,000.00 |
| Revenue This Year | N/A | $33.69 |
| Revenue Next Year | $472.48 | $24.74 |
| P/E Ratio | ★ N/A | $60.91 |
| Revenue Growth | N/A | ★ 46.06 |
| 52 Week Low | $21.71 | $12.70 |
| 52 Week High | $56.05 | $25.12 |
| Indicator | VERA | ALHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.69 | 41.12 |
| Support Level | $33.43 | $12.96 |
| Resistance Level | $42.77 | $22.62 |
| Average True Range (ATR) | 1.74 | 0.54 |
| MACD | 0.50 | 0.29 |
| Stochastic Oscillator | 66.17 | 57.03 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.